Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Transcriptomic profiling of human hippocampal progenitor cells treated with antidepressants and its application in drug repositioning.

Powell TR, Murphy T, Lee SH, Price J, Thuret S, Breen G.

J Psychopharmacol. 2017 Mar;31(3):338-345. doi: 10.1177/0269881117691467. Epub 2017 Feb 16.

2.

A role of Yueju in fast-onset antidepressant action on major depressive disorder and serum BDNF expression: a randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical study.

Wu R, Zhu D, Xia Y, Wang H, Tao W, Xue W, Xia B, Ren L, Zhou X, Li G, Chen G.

Neuropsychiatr Dis Treat. 2015 Aug 6;11:2013-21. doi: 10.2147/NDT.S86585. eCollection 2015.

3.

The potential utility of pharmacogenetic testing in psychiatry.

Gardner KR, Brennan FX, Scott R, Lombard J.

Psychiatry J. 2014;2014:730956. doi: 10.1155/2014/730956. Epub 2014 Dec 17. Review.

4.

Treatment-resistant depression in primary care across Canada.

Rizvi SJ, Grima E, Tan M, Rotzinger S, Lin P, Mcintyre RS, Kennedy SH.

Can J Psychiatry. 2014 Jul;59(7):349-57.

5.

Disturbance of the glutamatergic system in mood disorders.

Jun C, Choi Y, Lim SM, Bae S, Hong YS, Kim JE, Lyoo IK.

Exp Neurobiol. 2014 Mar;23(1):28-35. doi: 10.5607/en.2014.23.1.28. Epub 2014 Mar 27. Review.

6.

Rare copy number variation in treatment-resistant major depressive disorder.

O'Dushlaine C, Ripke S, Ruderfer DM, Hamilton SP, Fava M, Iosifescu DV, Kohane IS, Churchill SE, Castro VM, Clements CC, Blumenthal SR, Murphy SN, Smoller JW, Perlis RH.

Biol Psychiatry. 2014 Oct 1;76(7):536-41. doi: 10.1016/j.biopsych.2013.10.028. Epub 2014 Jan 19.

7.

Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims database.

Kubitz N, Mehra M, Potluri RC, Garg N, Cossrow N.

PLoS One. 2013 Oct 18;8(10):e76882. doi: 10.1371/journal.pone.0076882. eCollection 2013.

8.

DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP.

Powell TR, Smith RG, Hackinger S, Schalkwyk LC, Uher R, McGuffin P, Mill J, Tansey KE.

Transl Psychiatry. 2013 Sep 3;3:e300. doi: 10.1038/tp.2013.73.

9.

Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression.

Winner J, Allen JD, Altar CA, Spahic-Mihajlovic A.

Transl Psychiatry. 2013 Mar 19;3:e242. doi: 10.1038/tp.2013.2.

10.

Medical expenditures associated with major depressive disorder among privately insured working-age adults with diagnosed diabetes in the United States, 2008.

Shrestha SS, Zhang P, Li R, Thompson TJ, Chapman DP, Barker L.

Diabetes Res Clin Pract. 2013 Apr;100(1):102-10. doi: 10.1016/j.diabres.2013.02.002. Epub 2013 Mar 13.

11.

Resource utilization and costs associated with insomnia treatment in patients with major depressive disorder.

Tian H, Abouzaid S, Gabriel S, Kahler KH, Kim E.

Prim Care Companion CNS Disord. 2012;14(5). pii: PCC.12m01374. doi: 10.4088/PCC.12m01374. Epub 2012 Sep 27.

12.

A clinical risk stratification tool for predicting treatment resistance in major depressive disorder.

Perlis RH.

Biol Psychiatry. 2013 Jul 1;74(1):7-14. doi: 10.1016/j.biopsych.2012.12.007. Epub 2013 Feb 4.

13.

Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy.

Nadkarni A, Kalsekar I, You M, Forbes R, Hebden T.

Clinicoecon Outcomes Res. 2013;5:49-57. doi: 10.2147/CEOR.S36526. Epub 2013 Jan 20.

14.

The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: data from multicenter, prospective, longitudinal clinic practice.

Li Z, Zhang Y, Wang Z, Chen J, Fan J, Guan Y, Zhang C, Yuan C, Hong W, Wang Y, Wu Z, Huang J, Hu Y, Cao L, Yi Z, Cui D, Yu S, Fang Y.

J Psychiatr Res. 2013 Jan;47(1):8-14. doi: 10.1016/j.jpsychires.2012.10.003. Epub 2012 Nov 6.

15.

Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilance study.

Gallagher PJ, Castro V, Fava M, Weilburg JB, Murphy SN, Gainer VS, Churchill SE, Kohane IS, Iosifescu DV, Smoller JW, Perlis RH.

Am J Psychiatry. 2012 Oct;169(10):1065-72. doi: 10.1176/appi.ajp.2012.11091325.

16.

Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model.

Perlis RH, Iosifescu DV, Castro VM, Murphy SN, Gainer VS, Minnier J, Cai T, Goryachev S, Zeng Q, Gallagher PJ, Fava M, Weilburg JB, Churchill SE, Kohane IS, Smoller JW.

Psychol Med. 2012 Jan;42(1):41-50. doi: 10.1017/S0033291711000997. Epub 2011 Jun 20.

Supplemental Content

Support Center